Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients
- 366 Downloads
Symptomatic osteonecrosis related to corticosteroids has a high risk of progression to collapse in absence of treatment. The purposes of this study were to evaluate the results of autologous bone marrow grafting of the symptomatic hip in adult patients with osteonecrosis and to compare the results with core decompression alone in the contralateral symptomatic hip.
Materials and methods
A total of 125 consecutive patients (78 males and 47 females) with bilateral osteonecrosis (ON) and who had both hips symptomatic and at the same stage on each side (stage I or II) were included in this study from 1988 to 1998. The volume of osteonecrosis was measured with MRI in both hips; the smaller size ON was treated with core decompression, and the contralateral hip with the larger ON was treated with percutaneous mesenchymal cell (MSC) injection obtained from bone marrow concentration. The average total number of MSCs (counted as number of colony forming units-fibroblast) injected in each hip was 90,000 ± 25,000 cells (range 45,000 to 180,000 cells).
At the most recent FU (average 25 years after the first surgery, range 20 to 30 years), among the 250 hips included in the study, 35 hips (28%) had collapsed at the most recent follow-up after bone marrow grafting, and 90 (72%) after core decompression (CD). Ninety-five hips (76%) in the CD group underwent total hip replacement and 30 hips (24%) in the bone marrow graft group (p < 0.0001). Hips undergoing only CD were approximately three times more likely to undergo a primary THA (odds ratio: 10.0278; 95% CI: 5.6117 to 17.9190; p < 0.0001) as compared with hips undergoing an initial bone marrow grafting. For the 90 hips treated with bone marrow injection and without collapse, the mean volume of repair evaluated by MRI at the most recent follow-up was 16.4 cm3 (range 12 to 21 cm3) corresponding to a decrease of the pre-operative average volume from 22.4 cm3 (range 35–15 cm3) to 6 cm3 (range 12–0 cm3); as percentage of the volume of the femoral head, the decrease moved from 44.8 to 12%.
Core decompression with bone marrow injection improved the outcome of the disease as compared with core decompression alone in the same patient.
KeywordsHip osteonecrosis Cell therapy Mesenchymal stem cell Bone marrow Core decompression Corticosteroids
We thank Richard Suzuki of Celling Biosciences for the review of the final manuscript and help in translation.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Pietrogrande V, Mastromarino R (1957) Osteopathia da prolungato trattmento cortisonico. Ortop Tramatol 25:791–810Google Scholar
- 8.Hernigou P, Beaujean F (1993) La moëlle osseuse, une clé dans la compréhension des nécroses de hanche idiopathiques. Revue du Rhumatisme et des Maladies Ostéoarticulaires 60:722Google Scholar
- 9.Hernigou P, Beaujean F (1993) Bone marrow activity in the upper femoral extremity in avascular osteonecrosis. Rhum (Eng Ed) 60:610Google Scholar
- 12.Steinberg DR, Steinberg ME, Garino JP, Dalinka M, Udupa JK (2006) Determining lesion size in osteonecrosis of the femoral head. J Bone Joint Surg 88-A(Supplement 3):27–34Google Scholar
- 23.Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L et al (2012) Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone 50:325e30Google Scholar
- 24.Liu Y, Liu S, Su X (2013) Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head. Arch Orthop Trauma Surg 133:125e33Google Scholar
- 25.Lim YW, Kim YS, Lee JW, Kwon SY (2013) Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med 45:e61 128Google Scholar
- 27.Ma Y, Wang T, Liao J, Gu H, Lin X, Jiang Q et al (2014) Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther 5:115CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Tabatabaee RM, Saberi S, Parvizi J, Mortazavi SMJ, Farzan M (2015) Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplast 30(Suppl. 1):11–15CrossRefGoogle Scholar
- 29.Goodman SB (2018) The biological basis for concentrated iliac crest aspirate to enhance core decompression in the treatment of osteonecrosis. Int Orthop. https://doi.org/10.1007/s00264-018-3830-1
- 30.Hauzeur JP, De Maertelaer V, Baudoux E, Malaise M, Beguin Y, Gangji V (2017, 2017) Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop. https://doi.org/10.1007/s00264-017-3650-8
- 31.Uesugi Y, Sakai T, Seki T, Hayashi S, Nakamura J, Inaba Y, Takahashi D, Sasaki K, Motomura G, Mashima N, Kabata T, Sudo A, Jinno T, Ando W, Nagoya S, Yamamoto K, Nakasone S, Ito H, Yamamoto T, Sugano N (2018) Quality of life of patients with osteonecrosis of the femoral head: a multicentre study. Int Orthop. https://doi.org/10.1007/s00264-018-3897-8
- 32.Osawa Y, Seki T, Takegami Y, Kasai T, Higuchi Y, Ishiguro N (2018) Do femoral head collapse and the contralateral condition affect patient-reported quality of life and referral pain in patients with osteonecrosis of the femoral head? Int Orthop. https://doi.org/10.1007/s00264-018-3867-1
- 34.Merschin D, Häne R, Tohidnezhad M, Pufe T, Drescher W (2018) Bone-preserving total hip arthroplasty in avascular necrosis of the hip-a matched-pairs analysis. Int Orthop. https://doi.org/10.1007/s00264-018-3896-9
- 35.Chen DQ, Cancienne JM, Werner BC, Cui Q (2018) Is osteonecrosis due to systemic lupus erythematosus associated with increased risk of complications following total hip arthroplasty? Int Orthop. https://doi.org/10.1007/s00264-018-3871-5
- 39.Sugioka Y (1978) Transtrochanteric anterior rotational osteotomy of the femoral head in the treatment of osteonecrosis affecting the hip. Clin Orthop Relat Res 191–201Google Scholar
- 51.Lebouvier A, Poignard A, Cavet M, Amiaud J, Leotot J, Hernigou P, Rahmouni A, Bierling P, Layrolle P, Rouard H, Chevallier N (2015) Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection. Stem Cell Res Ther 15:584–594Google Scholar
- 52.Sionek A, Czwojdziński A, Kowalczewski J, Okoń T, Marczak D, Sibiński M, Złotorowicz M, Czubak J (2018) Hip osteonecroses treated with calcium sulfate-calcium phosphate bone graft substitute have different results according to the cause of osteonecrosis: alcohol abuse or corticosteroid-induced. Int Orthop. https://doi.org/10.1007/s00264-018-3892-0
- 53.Hamada H, Takao M, Sakai T, Sugano N (2018) Subchondral fracture begins from the bone resorption area in osteonecrosis of the femoral head: a micro-computerised tomography study. Int Orthop. https://doi.org/10.1007/s00264-018-3879-x
- 54.Peng Y, Liu Y, Huang D, Huang W, Shao Z (2018) Association of TNF-α-308(G/a) and −238(G/a) polymorphisms with non-traumatic osteonecrosis of the femoral head risks: a meta-analysis. Int Orthop. https://doi.org/10.1007/s00264-018-3859-1
- 55.Kubo Y, Motomura G, Ikemura S, Sonoda K, Hatanaka H, Utsunomiya T, Baba S, Nakashima Y (2018) The effect of the anterior boundary of necrotic lesion on the occurrence of collapse in osteonecrosis of the femoral head. Int Orthop. https://doi.org/10.1007/s00264-018-3836-8